EMA Urges Speed For Brexit-Related Variations Submissions
As the UK’s departure from the EU nears, the European Medicines Agency has published more guidance for companies that are planning to submit Brexit-related Type IA and Type IB variations.
As the UK’s departure from the EU nears, the European Medicines Agency has published more guidance for companies that are planning to submit Brexit-related Type IA and Type IB variations.